This post unpacks what actually happened, why a strategic buyer paid up for a 2019-era functional snack brand, what comparable transactions tell us about the multiple, and the lessons DTC founders running ecommerce businesses in the $5M to $100M revenue range should take from it.<\/p>\n\n\n\n
The deal at a glance<\/strong><\/h2>\n\n\n\nBel Group acquired Brainiac and Little Brainiac, both housed under Ingenuity Foods, a holding founded in 2017 by Jonathan Wolfson (former CEO of microalgae company TerraVia, which sold to Corbion) and Mark Brooks (former TerraVia SVP of food and ingredients). Brainiac launched its consumer line in 2019 with refrigerated kid-focused yogurts and tubes, then pivoted hard during the pandemic into shelf-stable fruit and vegetable squeeze pouches dosed with Omega-3 DHA, choline, lutein, and Vitamin C, all formulated to support brain development in kids.<\/p>\n\n\n\n
What buyers see in Brainiac:<\/strong><\/p>\n\n\n\n\n- Triple-digit value net sales growth in the trailing year before close<\/li>\n\n\n\n
- Patented shelf-stable functional formulation (US patent issued November 2025)<\/li>\n\n\n\n
- Distribution at scale through Walmart, Target, Kroger, and CVS<\/li>\n\n\n\n
- A defensible better-for-you positioning that is hard to copy without IP and clinical claims<\/li>\n\n\n\n
- Founder-led leadership that Bel kept in place post close, eliminating transition risk<\/li>\n<\/ul>\n\n\n\n
The signal Bel actually paid for:<\/strong> Brainiac was not the largest functional kids snack brand in the US. It was the cleanest fit with Bel’s GoGo squeeZ platform, with patented formulations, retail velocity, and a founder team Bel was willing to retain. Strategic buyers pay premiums for fit, not size.<\/p>\n\n\n\nWhy a strategic bought, not a financial<\/strong><\/h2>\n\n\n\nBrainiac’s investor cap table includes Luxe Capital, Lerer Hippeau, Slow Ventures, 7GC, Kygo Ventures, and Montage Ventures. Any of those funds would have been comfortable with a financial exit to a private equity sponsor or a search fund. Brainiac did not go that way. The buyer was Bel Group, a public European strategic with a proven snacking M&A playbook.<\/p>\n\n\n\n
The reason matters for any DTC founder thinking about who their eventual buyer should be. Strategic buyers, when the fit is right, pay more than financial buyers. They pay for revenue synergies that a financial buyer cannot model: Bel can put Brainiac into the same broker network that distributes GoGo squeeZ, the same Babybel placement at school lunch programs, and the same European launch infrastructure that took GoGo squeeZ international. A financial buyer paying out of a fund cannot generate any of that.<\/p>\n\n\n\n
What strategic buyers will pay extra for:<\/strong><\/p>\n\n\n\n\n- Distribution leverage: their existing retail relationships unlock new revenue overnight<\/li>\n\n\n\n
- Category complementarity: the brand expands a portfolio without cannibalizing it<\/li>\n\n\n\n
- Defensible IP: patents, formulations, and trademarks they cannot easily replicate<\/li>\n\n\n\n
- Talent retention: founders willing to stay on through a transition or earnout<\/li>\n<\/ul>\n\n\n\n
For DTC founders in the $5M to $50M revenue range, this is the highest-leverage decision in a sale: identifying which strategic buyer actually has a portfolio gap your brand fills, then building a CIM and outreach process that targets those strategics specifically. The deeper view of how this comes together is in the guide on how to build a sellable DTC brand from day one<\/a>.<\/p>\n\n\n\n![\"\"](\"https:\/\/ecomswap.io\/blog\/wp-content\/uploads\/2026\/05\/image-24.jpg\")
<\/figure>\n\n\n\nWhat made Brainiac actually sellable<\/strong><\/h2>\n\n\n\nBrainiac is a useful case study because it did not look like a typical DTC darling. It is a CPG brand that sells at retail, with a real innovation moat (a US patent on shelf-stable nutritionally enhanced products granted in November 2025), and a category position that mainstream snacking buyers understand. Five attributes made it sellable to a strategic at a strong multiple.<\/p>\n\n\n\n
The five sellability drivers:<\/strong><\/p>\n\n\n\n\n- Functional positioning. <\/strong>Brainiac was not “another fruit pouch.” It was the brain-development fruit pouch with named, dosed nutrients (Omega-3 DHA, choline, lutein). That converts skeptical retail buyers and creates a pricing ceiling above generic competitors.<\/li>\n\n\n\n
- Retail velocity at scale. <\/strong>Walmart, Target, Kroger, CVS. Strategic buyers will not pay for a brand that lives only on Amazon and a Shopify store. They pay for shelf footprint they can expand.<\/li>\n\n\n\n
- Patented IP. <\/strong>A November 2025 US patent on shelf-stable nutritionally enhanced products gave Bel a moat it could not buy elsewhere. IP shows up in valuation as both a multiple expansion and a deal-protection layer.<\/li>\n\n\n\n
- Founder optionality. <\/strong>Wolfson and Brooks were retained post close. A clean founder transition removes a buyer’s biggest perceived risk.<\/li>\n\n\n\n
- Growth on the right curve. <\/strong>Triple-digit growth in the trailing year. Buyers pay for trajectory, not just revenue. A flat $50M brand sells at a lower multiple than a $25M brand growing 100 percent.<\/li>\n<\/ul>\n\n\n\n
The most common DTC sellability issue:<\/strong> founders confuse “growing fast” with “sellable.” Growth without distribution, defensible IP, or strategic fit produces a great founder story and a thin acquirer pool. Sellability is the intersection of growth and what a strategic actually wants to buy.<\/p>\n\n\n\nThe deeper view of these drivers, including the seven-factor scorecard most buyers use, is in the DTC brand valuation guide<\/a>.<\/p>\n\n\n\nWhat the comparables tell us about the multiple<\/strong><\/h2>\n\n\n\nBel did not disclose the deal value, but Drew Fallon’s breakdown of the transaction cited two recent comparables that bracket the likely range:<\/p>\n\n\n\n
Recent functional snack and DTC food comparables:<\/strong><\/p>\n\n\n\n\n- Nexus Capital acquired Laird Superfood for $50M at roughly 0.9x sales (financial buyer, distressed margin profile)<\/strong><\/li>\n\n\n\n
- Candy Kittens acquired graze for $48M at roughly 1.0x sales (strategic buyer, stagnant growth)<\/strong><\/li>\n<\/ul>\n\n\n\n
Both comparables landed near 1x sales. That is the floor for an underperforming or flat DTC food brand. Brainiac would not have signed on similar terms. With triple-digit growth, patented IP, retail distribution, and a clear strategic fit, the realistic multiple is meaningfully higher. A reasonable working assumption is 2x to 3x sales for a brand with that profile, which would put the deal in the $80M to $200M range depending on Brainiac’s actual TTM revenue. That number is speculative because Bel did not disclose, but the structure of the comparables tells us the multiple was not at the 1x floor.<\/p>\n\n\n\n
There is a second nuance worth pulling out. The Laird and graze deals were sold under different market conditions: Laird was bought by a fund focused on distressed and special situations, and graze had been part of Unilever before the Candy Kittens transaction, which was effectively a divestiture rather than a competitive auction. Brainiac was the opposite. It went into a process where the brand was growing, the IP was patented, and the strategic fit was specific. Buyers who pay a premium do so because the brand is rare, not because the seller is desperate. Founders who study comparables without understanding the conditions of those comparables consistently misprice their own business by 20 to 40 percent in either direction.<\/p>\n\n\n\n
The most common multiple miscalculation:<\/strong> founders compare their business to the headline multiples in trade publications, then ignore the qualitative differences (growth, IP, distribution, founder fit) that drove those multiples up or down. The same revenue can sell at 0.7x or 3x depending on five or six attributes that are knowable in advance.<\/p>\n\n\n\nA useful gut check is the broader ecommerce multiples 2026 framework<\/a>, which decomposes how trailing growth, channel mix, and gross margin combine to set the range a buyer will pay.<\/p>\n\n\n\n![\"\"](\"https:\/\/ecomswap.io\/blog\/wp-content\/uploads\/2026\/05\/image-23.jpg\")
<\/figure>\n\n\n\nThe complementary platform thesis<\/strong><\/h2>\n\n\n\nBel’s acquisition rationale, in their own press materials, was that Brainiac was complementary to GoGo squeeZ. That single word, complementary, is doing a lot of work and it is the framing every DTC founder should study before they go to market.<\/p>\n\n\n\n
Bel already owned the GoGo squeeZ platform from its 2016 acquisition of MOM Group (completed to 100 percent ownership in 2022). That platform sells fruit and vegetable squeeze pouches across mainstream retail. What it did not have was a defensible, premium-priced functional positioning aimed at parents who wanted nutrient-dosed snacks for cognitive development. Brainiac fills that gap without cannibalizing GoGo squeeZ’s mainstream price point.<\/p>\n\n\n\n
What “complementary” looks like to a buyer:<\/strong><\/p>\n\n\n\n\n- Same channel, same shelf, same buyer relationships, but a different shopper occasion<\/li>\n\n\n\n
- Premium price point above the existing portfolio, expanding ASP without cannibalization<\/li>\n\n\n\n
- Functional or claim-based moat the buyer cannot easily build internally<\/li>\n\n\n\n
- Operational fit: similar manufacturing, similar SKU complexity, no big integration cost<\/li>\n<\/ul>\n\n\n\n
For founders running a DTC brand today, the test is mechanical: list the five strategics most likely to buy your business, then ask which gap each of them has in their existing portfolio. If you cannot name a specific gap your brand fills for at least two strategics, you are not yet building a brand that sells at a strategic premium. You are building a brand that sells at the financial-buyer floor.<\/p>\n\n\n\n
Lessons for DTC founders preparing to exit<\/strong><\/h2>\n\n\n\nThe Brainiac exit reads like a textbook on what a sellable DTC brand looks like in 2026. Six things stand out for founders who are 12 to 36 months from their own potential exit.<\/p>\n\n\n\n
Six takeaways for sellers:<\/strong><\/p>\n\n\n\n\n- Build for a buyer, not for an investor. <\/strong>A pitch deck that wins a Series B is not the same as a CIM that wins a strategic acquisition. The earlier a founder thinks about who buys this in five years, the cleaner the brand decisions become.<\/li>\n\n\n\n
- Patent the formulation. <\/strong>IP is not a vanity asset. Brainiac’s November 2025 patent gave Bel a defensible moat to underwrite the multiple. If the brand has a real formulation, file early.<\/li>\n\n\n\n
- Win retail before you go to market. <\/strong>Strategic buyers in CPG do not pay strategic premiums for Amazon-only brands. Mainstream retail distribution is what triggers the synergy math.<\/li>\n\n\n\n
- Stay growing through diligence. <\/strong>Triple-digit growth is not the requirement. Positive trailing growth is. A brand that flatlines during the six-month sale process gets repriced 10 to 20 percent every time.<\/li>\n\n\n\n
- Be willing to stay post close. <\/strong>Strategic buyers want founders to stay through transition. Founders who insist on a clean exit at close lose multiple turns of valuation.<\/li>\n\n\n\n
- Run a process, not a pitch. <\/strong>Brainiac did not happen by Bel knocking on the door. A specialist process surfaces the right strategic, runs the LOI auction, and protects the multiple. The mistakes founders make when they skip a process are catalogued in the breakdown of the top mistakes DTC founders make when selling<\/a>.<\/li>\n<\/ul>\n\n\n\n
What this signals for the rest of 2026<\/strong><\/h2>\n\n\n\nBel’s Brainiac acquisition is the clearest signal yet that strategic buyers in better-for-you snacking are back to writing real checks for DTC and emerging brands with proven retail traction and defensible positioning. After two years of weak strategic activity in CPG, the deal flow in May 2026 looks meaningfully different from May 2025. Aggregators and search funds are still active in the smaller end of the market, but the strategic premium for brands with patents, retail distribution, and category-defining positioning is back to pre-2024 levels.<\/p>\n\n\n\n
What sellers should expect over the next 90 days:<\/strong><\/p>\n\n\n\n\n- More strategic buyers running active scout programs in functional, plant-based, and kid-focused categories<\/li>\n\n\n\n
- Multiples expanding for brands with patented or claim-based moats, even at smaller revenue<\/li>\n\n\n\n
- Continued discount for Amazon-only or DTC-only brands without retail distribution<\/li>\n\n\n\n
- LOI to close timelines compressing to 90 to 120 days for high-fit strategic deals<\/li>\n<\/ul>\n\n\n\n
The single most actionable read:<\/strong> if a brand has a defensible position in a category a Big CPG strategic is missing, the next 6 to 12 months are the right window to start preparing. The cost of waiting is the chance the strategic builds the capability internally or buys a competitor.<\/p>\n\n\n\n![\"\"](\"https:\/\/ecomswap.io\/blog\/wp-content\/uploads\/2026\/05\/image-22.jpg\")
<\/figure>\n\n\n\nBottom line<\/strong><\/h2>\n\n\n\nBel’s acquisition of Brainiac is not a one-off CPG headline. It is a working example of what a sellable DTC brand looks like to a strategic buyer in 2026: triple-digit growth, real distribution, patented IP, complementary fit with the buyer’s existing portfolio, and a founding team willing to stay through transition. Founders who can engineer those five attributes into the next 12 to 24 months of their business plan are positioning for a strategic exit at a premium multiple. Founders who cannot are positioning for a financial-buyer exit at the 1x floor.<\/p>\n\n\n\n
The deal also confirms what brokers have been telling sellers for two quarters: the strategic premium is real again, the buyers are active, and the brands that move first will compress timelines and pull stronger LOIs. The brands that wait will be reading the next press release about a competitor that did not. The right next step for a founder considering an exit is a conversation about who the realistic strategic buyers are, what gaps your brand actually fills for them, and whether the timing is right. The framework for that conversation is in the guide on working with an ecommerce broker<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"On May 6, 2026, Paris-based Bel Group, the \u20ac3.74 billion dairy and snack conglomerate behind Babybel, GoGo squeeZ, The Laughing Cow, and Boursin, announced the acquisition of Ingenuity Foods’s Brainiac and Little Brainiac brands. The deal value was not disclosed, but Brainiac came into the transaction posting triple-digit value net sales growth and slotted directly […]<\/p>\n","protected":false},"author":4,"featured_media":1353,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard"},"jnews_primary_category":[],"jnews_override_counter":[],"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1348","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"jetpack_featured_media_url":"https:\/\/ecomswap.io\/blog\/wp-content\/uploads\/2026\/05\/image.png","_links":{"self":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts\/1348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/comments?post=1348"}],"version-history":[{"count":1,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts\/1348\/revisions"}],"predecessor-version":[{"id":1354,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts\/1348\/revisions\/1354"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/media\/1353"}],"wp:attachment":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/media?parent=1348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/categories?post=1348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/tags?post=1348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- \n
- Triple-digit value net sales growth in the trailing year before close<\/li>\n\n\n\n
- Patented shelf-stable functional formulation (US patent issued November 2025)<\/li>\n\n\n\n
- Distribution at scale through Walmart, Target, Kroger, and CVS<\/li>\n\n\n\n
- A defensible better-for-you positioning that is hard to copy without IP and clinical claims<\/li>\n\n\n\n
- Founder-led leadership that Bel kept in place post close, eliminating transition risk<\/li>\n<\/ul>\n\n\n\n
The signal Bel actually paid for:<\/strong> Brainiac was not the largest functional kids snack brand in the US. It was the cleanest fit with Bel’s GoGo squeeZ platform, with patented formulations, retail velocity, and a founder team Bel was willing to retain. Strategic buyers pay premiums for fit, not size.<\/p>\n\n\n\n
Why a strategic bought, not a financial<\/strong><\/h2>\n\n\n\n
Brainiac’s investor cap table includes Luxe Capital, Lerer Hippeau, Slow Ventures, 7GC, Kygo Ventures, and Montage Ventures. Any of those funds would have been comfortable with a financial exit to a private equity sponsor or a search fund. Brainiac did not go that way. The buyer was Bel Group, a public European strategic with a proven snacking M&A playbook.<\/p>\n\n\n\n
The reason matters for any DTC founder thinking about who their eventual buyer should be. Strategic buyers, when the fit is right, pay more than financial buyers. They pay for revenue synergies that a financial buyer cannot model: Bel can put Brainiac into the same broker network that distributes GoGo squeeZ, the same Babybel placement at school lunch programs, and the same European launch infrastructure that took GoGo squeeZ international. A financial buyer paying out of a fund cannot generate any of that.<\/p>\n\n\n\n
What strategic buyers will pay extra for:<\/strong><\/p>\n\n\n\n
- \n
- Distribution leverage: their existing retail relationships unlock new revenue overnight<\/li>\n\n\n\n
- Category complementarity: the brand expands a portfolio without cannibalizing it<\/li>\n\n\n\n
- Defensible IP: patents, formulations, and trademarks they cannot easily replicate<\/li>\n\n\n\n
- Talent retention: founders willing to stay on through a transition or earnout<\/li>\n<\/ul>\n\n\n\n
For DTC founders in the $5M to $50M revenue range, this is the highest-leverage decision in a sale: identifying which strategic buyer actually has a portfolio gap your brand fills, then building a CIM and outreach process that targets those strategics specifically. The deeper view of how this comes together is in the guide on how to build a sellable DTC brand from day one<\/a>.<\/p>\n\n\n\n
<\/figure>\n\n\n\nWhat made Brainiac actually sellable<\/strong><\/h2>\n\n\n\n
Brainiac is a useful case study because it did not look like a typical DTC darling. It is a CPG brand that sells at retail, with a real innovation moat (a US patent on shelf-stable nutritionally enhanced products granted in November 2025), and a category position that mainstream snacking buyers understand. Five attributes made it sellable to a strategic at a strong multiple.<\/p>\n\n\n\n
The five sellability drivers:<\/strong><\/p>\n\n\n\n
- \n
- Functional positioning. <\/strong>Brainiac was not “another fruit pouch.” It was the brain-development fruit pouch with named, dosed nutrients (Omega-3 DHA, choline, lutein). That converts skeptical retail buyers and creates a pricing ceiling above generic competitors.<\/li>\n\n\n\n
- Retail velocity at scale. <\/strong>Walmart, Target, Kroger, CVS. Strategic buyers will not pay for a brand that lives only on Amazon and a Shopify store. They pay for shelf footprint they can expand.<\/li>\n\n\n\n
- Patented IP. <\/strong>A November 2025 US patent on shelf-stable nutritionally enhanced products gave Bel a moat it could not buy elsewhere. IP shows up in valuation as both a multiple expansion and a deal-protection layer.<\/li>\n\n\n\n
- Founder optionality. <\/strong>Wolfson and Brooks were retained post close. A clean founder transition removes a buyer’s biggest perceived risk.<\/li>\n\n\n\n
- Growth on the right curve. <\/strong>Triple-digit growth in the trailing year. Buyers pay for trajectory, not just revenue. A flat $50M brand sells at a lower multiple than a $25M brand growing 100 percent.<\/li>\n<\/ul>\n\n\n\n
The most common DTC sellability issue:<\/strong> founders confuse “growing fast” with “sellable.” Growth without distribution, defensible IP, or strategic fit produces a great founder story and a thin acquirer pool. Sellability is the intersection of growth and what a strategic actually wants to buy.<\/p>\n\n\n\n
The deeper view of these drivers, including the seven-factor scorecard most buyers use, is in the DTC brand valuation guide<\/a>.<\/p>\n\n\n\n
What the comparables tell us about the multiple<\/strong><\/h2>\n\n\n\n
Bel did not disclose the deal value, but Drew Fallon’s breakdown of the transaction cited two recent comparables that bracket the likely range:<\/p>\n\n\n\n
Recent functional snack and DTC food comparables:<\/strong><\/p>\n\n\n\n
- \n
- Nexus Capital acquired Laird Superfood for $50M at roughly 0.9x sales (financial buyer, distressed margin profile)<\/strong><\/li>\n\n\n\n
- Candy Kittens acquired graze for $48M at roughly 1.0x sales (strategic buyer, stagnant growth)<\/strong><\/li>\n<\/ul>\n\n\n\n
Both comparables landed near 1x sales. That is the floor for an underperforming or flat DTC food brand. Brainiac would not have signed on similar terms. With triple-digit growth, patented IP, retail distribution, and a clear strategic fit, the realistic multiple is meaningfully higher. A reasonable working assumption is 2x to 3x sales for a brand with that profile, which would put the deal in the $80M to $200M range depending on Brainiac’s actual TTM revenue. That number is speculative because Bel did not disclose, but the structure of the comparables tells us the multiple was not at the 1x floor.<\/p>\n\n\n\n
There is a second nuance worth pulling out. The Laird and graze deals were sold under different market conditions: Laird was bought by a fund focused on distressed and special situations, and graze had been part of Unilever before the Candy Kittens transaction, which was effectively a divestiture rather than a competitive auction. Brainiac was the opposite. It went into a process where the brand was growing, the IP was patented, and the strategic fit was specific. Buyers who pay a premium do so because the brand is rare, not because the seller is desperate. Founders who study comparables without understanding the conditions of those comparables consistently misprice their own business by 20 to 40 percent in either direction.<\/p>\n\n\n\n
The most common multiple miscalculation:<\/strong> founders compare their business to the headline multiples in trade publications, then ignore the qualitative differences (growth, IP, distribution, founder fit) that drove those multiples up or down. The same revenue can sell at 0.7x or 3x depending on five or six attributes that are knowable in advance.<\/p>\n\n\n\n
A useful gut check is the broader ecommerce multiples 2026 framework<\/a>, which decomposes how trailing growth, channel mix, and gross margin combine to set the range a buyer will pay.<\/p>\n\n\n\n
<\/figure>\n\n\n\nThe complementary platform thesis<\/strong><\/h2>\n\n\n\n
Bel’s acquisition rationale, in their own press materials, was that Brainiac was complementary to GoGo squeeZ. That single word, complementary, is doing a lot of work and it is the framing every DTC founder should study before they go to market.<\/p>\n\n\n\n
Bel already owned the GoGo squeeZ platform from its 2016 acquisition of MOM Group (completed to 100 percent ownership in 2022). That platform sells fruit and vegetable squeeze pouches across mainstream retail. What it did not have was a defensible, premium-priced functional positioning aimed at parents who wanted nutrient-dosed snacks for cognitive development. Brainiac fills that gap without cannibalizing GoGo squeeZ’s mainstream price point.<\/p>\n\n\n\n
What “complementary” looks like to a buyer:<\/strong><\/p>\n\n\n\n
- \n
- Same channel, same shelf, same buyer relationships, but a different shopper occasion<\/li>\n\n\n\n
- Premium price point above the existing portfolio, expanding ASP without cannibalization<\/li>\n\n\n\n
- Functional or claim-based moat the buyer cannot easily build internally<\/li>\n\n\n\n
- Operational fit: similar manufacturing, similar SKU complexity, no big integration cost<\/li>\n<\/ul>\n\n\n\n
For founders running a DTC brand today, the test is mechanical: list the five strategics most likely to buy your business, then ask which gap each of them has in their existing portfolio. If you cannot name a specific gap your brand fills for at least two strategics, you are not yet building a brand that sells at a strategic premium. You are building a brand that sells at the financial-buyer floor.<\/p>\n\n\n\n
Lessons for DTC founders preparing to exit<\/strong><\/h2>\n\n\n\n
The Brainiac exit reads like a textbook on what a sellable DTC brand looks like in 2026. Six things stand out for founders who are 12 to 36 months from their own potential exit.<\/p>\n\n\n\n
Six takeaways for sellers:<\/strong><\/p>\n\n\n\n
- \n
- Build for a buyer, not for an investor. <\/strong>A pitch deck that wins a Series B is not the same as a CIM that wins a strategic acquisition. The earlier a founder thinks about who buys this in five years, the cleaner the brand decisions become.<\/li>\n\n\n\n
- Patent the formulation. <\/strong>IP is not a vanity asset. Brainiac’s November 2025 patent gave Bel a defensible moat to underwrite the multiple. If the brand has a real formulation, file early.<\/li>\n\n\n\n
- Win retail before you go to market. <\/strong>Strategic buyers in CPG do not pay strategic premiums for Amazon-only brands. Mainstream retail distribution is what triggers the synergy math.<\/li>\n\n\n\n
- Stay growing through diligence. <\/strong>Triple-digit growth is not the requirement. Positive trailing growth is. A brand that flatlines during the six-month sale process gets repriced 10 to 20 percent every time.<\/li>\n\n\n\n
- Be willing to stay post close. <\/strong>Strategic buyers want founders to stay through transition. Founders who insist on a clean exit at close lose multiple turns of valuation.<\/li>\n\n\n\n
- Run a process, not a pitch. <\/strong>Brainiac did not happen by Bel knocking on the door. A specialist process surfaces the right strategic, runs the LOI auction, and protects the multiple. The mistakes founders make when they skip a process are catalogued in the breakdown of the top mistakes DTC founders make when selling<\/a>.<\/li>\n<\/ul>\n\n\n\n
What this signals for the rest of 2026<\/strong><\/h2>\n\n\n\n
Bel’s Brainiac acquisition is the clearest signal yet that strategic buyers in better-for-you snacking are back to writing real checks for DTC and emerging brands with proven retail traction and defensible positioning. After two years of weak strategic activity in CPG, the deal flow in May 2026 looks meaningfully different from May 2025. Aggregators and search funds are still active in the smaller end of the market, but the strategic premium for brands with patents, retail distribution, and category-defining positioning is back to pre-2024 levels.<\/p>\n\n\n\n
What sellers should expect over the next 90 days:<\/strong><\/p>\n\n\n\n
- \n
- More strategic buyers running active scout programs in functional, plant-based, and kid-focused categories<\/li>\n\n\n\n
- Multiples expanding for brands with patented or claim-based moats, even at smaller revenue<\/li>\n\n\n\n
- Continued discount for Amazon-only or DTC-only brands without retail distribution<\/li>\n\n\n\n
- LOI to close timelines compressing to 90 to 120 days for high-fit strategic deals<\/li>\n<\/ul>\n\n\n\n
The single most actionable read:<\/strong> if a brand has a defensible position in a category a Big CPG strategic is missing, the next 6 to 12 months are the right window to start preparing. The cost of waiting is the chance the strategic builds the capability internally or buys a competitor.<\/p>\n\n\n\n
<\/figure>\n\n\n\nBottom line<\/strong><\/h2>\n\n\n\n
Bel’s acquisition of Brainiac is not a one-off CPG headline. It is a working example of what a sellable DTC brand looks like to a strategic buyer in 2026: triple-digit growth, real distribution, patented IP, complementary fit with the buyer’s existing portfolio, and a founding team willing to stay through transition. Founders who can engineer those five attributes into the next 12 to 24 months of their business plan are positioning for a strategic exit at a premium multiple. Founders who cannot are positioning for a financial-buyer exit at the 1x floor.<\/p>\n\n\n\n
The deal also confirms what brokers have been telling sellers for two quarters: the strategic premium is real again, the buyers are active, and the brands that move first will compress timelines and pull stronger LOIs. The brands that wait will be reading the next press release about a competitor that did not. The right next step for a founder considering an exit is a conversation about who the realistic strategic buyers are, what gaps your brand actually fills for them, and whether the timing is right. The framework for that conversation is in the guide on working with an ecommerce broker<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"
On May 6, 2026, Paris-based Bel Group, the \u20ac3.74 billion dairy and snack conglomerate behind Babybel, GoGo squeeZ, The Laughing Cow, and Boursin, announced the acquisition of Ingenuity Foods’s Brainiac and Little Brainiac brands. The deal value was not disclosed, but Brainiac came into the transaction posting triple-digit value net sales growth and slotted directly […]<\/p>\n","protected":false},"author":4,"featured_media":1353,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard"},"jnews_primary_category":[],"jnews_override_counter":[],"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1348","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"jetpack_featured_media_url":"https:\/\/ecomswap.io\/blog\/wp-content\/uploads\/2026\/05\/image.png","_links":{"self":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts\/1348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/comments?post=1348"}],"version-history":[{"count":1,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts\/1348\/revisions"}],"predecessor-version":[{"id":1354,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/posts\/1348\/revisions\/1354"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/media\/1353"}],"wp:attachment":[{"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/media?parent=1348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/categories?post=1348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ecomswap.io\/blog\/wp-json\/wp\/v2\/tags?post=1348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- Patent the formulation. <\/strong>IP is not a vanity asset. Brainiac’s November 2025 patent gave Bel a defensible moat to underwrite the multiple. If the brand has a real formulation, file early.<\/li>\n\n\n\n
- Build for a buyer, not for an investor. <\/strong>A pitch deck that wins a Series B is not the same as a CIM that wins a strategic acquisition. The earlier a founder thinks about who buys this in five years, the cleaner the brand decisions become.<\/li>\n\n\n\n
- Candy Kittens acquired graze for $48M at roughly 1.0x sales (strategic buyer, stagnant growth)<\/strong><\/li>\n<\/ul>\n\n\n\n
- Retail velocity at scale. <\/strong>Walmart, Target, Kroger, CVS. Strategic buyers will not pay for a brand that lives only on Amazon and a Shopify store. They pay for shelf footprint they can expand.<\/li>\n\n\n\n
- Functional positioning. <\/strong>Brainiac was not “another fruit pouch.” It was the brain-development fruit pouch with named, dosed nutrients (Omega-3 DHA, choline, lutein). That converts skeptical retail buyers and creates a pricing ceiling above generic competitors.<\/li>\n\n\n\n